Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

No significant link between hair loss and iron or thyroid levels was found, but checking for deficiencies might still be useful.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Environmental factors and exposure to toxins may contribute to male infertility by affecting sperm and hormone function.

Melatonin may help manage PCOS by improving insulin sensitivity, hormone balance, and mood.

Despite progress, better treatments and understanding are needed for the high rates of long-term issues and deaths linked to eating disorders.

Topical minoxidil helps treat hair loss in teens, but more research needed for safe options.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

The document concludes that scalp disorders can be treated with hair washing, specific shampoos, medications, and sometimes surgery or hair transplants, but hereditary baldness is untreatable.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Finasteride effectively stops hair loss in most patients, but concerns about rare sexual side effects exist.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

The new test can measure very small amounts of testosterone in hair, and grinding the hair up first gives more accurate results.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.